ConductScience.org, home

Paper37562003

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.

Leiding JW and 68 others. Blood, 2023. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Papers, record 37562003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37562003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
PubMed
Journal
Blood
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
3.53
iCite
Revised in PubMed
2025-05-30
PubMed

Authors69

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leiding JWJennifer Whttps://orcid.org/0000-0002-7573-9390
2Arnold DEDanielle Ehttps://orcid.org/0000-0001-7501-806X
3Parikh SSuhaghttps://orcid.org/0000-0002-6066-9852
4Logan BBrent
5Marsh RARebecca A
6Griffith LMLinda M
7Wu RRuizhe
8Kidd SSharon
9Mallhi KKanwaldeep
10Chellapandian DDeepakhttps://orcid.org/0000-0003-3518-9790
11Si Lim SJStephanie Jhttps://orcid.org/0000-0001-5983-581X
12Grunebaum EEyal
13Falcone ELE Liana
14Murguia-Favela LLuishttps://orcid.org/0000-0001-6893-3366
15Grossman DDebbi
16Prasad VKVinod Khttps://orcid.org/0000-0001-8151-8212
17Heimall JRJennifer R
18Touzot FFabienhttps://orcid.org/0000-0002-0889-4905
19Burroughs LMLauri M
20Bleesing JJack

Source PubMed

See all 69 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Granulomatous Disease, ChronicMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Graft vs Host DiseaseMajor topic
Humans
Retrospective Studies
Prospective Studies
Transplantation, Homologous
Genotype
Transplantation Conditioning

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 TR001263NCATS NIH HHSUnited StatesU01TR001263PubMed and NIHNIH RePORTER
UL1 TR002494NCATS NIH HHSUnited StatesUL1TR002494PubMed and NIHNIH RePORTER
U24 CA076518NCI NIH HHSUnited StatesU24CA076518PubMed and NIHNIH RePORTER
U54 AI082973NIAID NIH HHSUnited StatesU54AI082973PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMedNIH RePORTER
KL2 TR002492NCATS NIH HHSUnited StatesKL2TR002492PubMed and NIHNIH RePORTER
U01 HL069294NHLBI NIH HHSUnited StatesU01HL069294PubMed and NIHNIH RePORTER
U54 NS064808NINDS NIH HHSUnited StatesU54NS064808PubMed and NIHNIH RePORTER
ZIA AI001222Intramural NIH HHSUnited StatesZIAAI001222PubMedNIH RePORTER
Z01 AI000644Intramural NIH HHSUnited StatesZIAAI000644PubMed and NIHNIH RePORTER
U10 HL069254NHLBI NIH HHSUnited StatesU10HL069254PubMed and NIHNIH RePORTER
R13 AI094943NIAID NIH HHSUnited StatesR13AI094943PubMedNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02082353Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in38095925HCT alleviates disease burden in CGD.https://conductscience.org/library/papers/38095925

Source PubMed

Download CSV of comments and corrections

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125537876Common severe infections in chronic granulomatous disease.Clin Infect Dis2015https://conductscience.org/library/papers/25537876PubMed
221190454Residual NADPH oxidase and survival in chronic granulomatous disease.N Engl J Med2010https://conductscience.org/library/papers/21190454PubMed
327543157
A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
Biol Blood Marrow Transplant2016https://conductscience.org/library/papers/27543157PubMed
47004534Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.Blood1981https://conductscience.org/library/papers/7004534PubMed
519222467Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.Br J Haematol2009https://conductscience.org/library/papers/19222467PubMed
675810761994 Consensus Conference on Acute GVHD Grading.Bone Marrow Transplant1995https://conductscience.org/library/papers/7581076PubMed
723011479
Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.
J Clin Immunol2013https://conductscience.org/library/papers/23011479PubMed
828752258Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.J Clin Immunol2017https://conductscience.org/library/papers/28752258PubMed
926644451Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT.Blood2016https://conductscience.org/library/papers/26644451PubMed
1032801991Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease.Pediatric Health Med Ther2020https://conductscience.org/library/papers/32801991PubMed
1131376032Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.J Clin Immunol2019https://conductscience.org/library/papers/31376032PubMed
1232849547Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.Front Immunol2020https://conductscience.org/library/papers/32849547PubMed
1331228584Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/31228584PubMed
1434548626A prospective pilot study of a novel alemtuzumab target concentration intervention strategy.Bone Marrow Transplant2021https://conductscience.org/library/papers/34548626PubMed
1535033700Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry.J Allergy Clin Immunol Pract2022https://conductscience.org/library/papers/35033700PubMed
1632614953Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.Blood2020https://conductscience.org/library/papers/32614953PubMed
1718037347Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.Clin Immunol2008https://conductscience.org/library/papers/18037347PubMed
1810844935Chronic granulomatous disease. Report on a national registry of 368 patients.Medicine (Baltimore)2000https://conductscience.org/library/papers/10844935PubMed
1918410635Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.Clin Exp Immunol2008https://conductscience.org/library/papers/18410635PubMed
2029746679Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.J Pediatric Infect Dis Soc2018https://conductscience.org/library/papers/29746679PubMed

See all 24 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42352030Molecular Views into the Synthesis and Activation of Flavocytochrome b558 in Phagocytic Cells-Focus on the Role of EROS.Antioxidants (Basel)2026https://conductscience.org/library/papers/42352030PubMed
42170004How I Treat: Chronic granulomatous disease.J Hum Immun2026https://conductscience.org/library/papers/42170004PubMed
42169994Hematopoietic stem cell transplantation following invasive mold infection in chronic granulomatous disease: Insights from a case series and literature review.J Hum Immun2026https://conductscience.org/library/papers/42169994PubMed
41660618Atopy and immune dysregulation among patients with chronic granulomatous disease.Front Immunol2025https://conductscience.org/library/papers/41660618PubMed
41046057Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report.Transplant Cell Ther2026https://conductscience.org/library/papers/41046057PubMed
40278093Invasive Fungal Infection by Scedosporium apiospermum with Cerebral Involvement in a Pediatric Patient Affected by Chronic Granulomatous Disease After Hematopoietic Cell Transplant.J Fungi (Basel)2025https://conductscience.org/library/papers/40278093PubMed
40227295The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel)2025https://conductscience.org/library/papers/40227295PubMed
39746704[Refractory or resistant cytomegalovirus infections after hematopoietic stem cell transplantation: diagnosis and management].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39746704PubMed
39665712Implementation of a Pilot Study in Adolescent Health Care Transition Program for Chronic Granulomatous Disease: A Single Institution Experience.J Pediatr Health Care2025https://conductscience.org/library/papers/39665712PubMed
39496935Mold infections in chronic granulomatous disease patients-what comes to the rescue?Bone Marrow Transplant2025https://conductscience.org/library/papers/39496935PubMed
39332496Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease.J Allergy Clin Immunol Pract2024https://conductscience.org/library/papers/39332496PubMed
39278553High symptom burden in female X-linked chronic granulomatous disease carriers.Clin Immunol2024https://conductscience.org/library/papers/39278553PubMed
39005504Clinical presentation, diagnosis, and treatment of chronic granulomatous disease.Front Pediatr2024https://conductscience.org/library/papers/39005504PubMed
38429865Functional neutrophil disorders: Chronic granulomatous disease and beyond.Immunol Rev2024https://conductscience.org/library/papers/38429865PubMed
38290608Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.J Allergy Clin Immunol2024https://conductscience.org/library/papers/38290608PubMed
37763024Haematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.J Clin Med2023https://conductscience.org/library/papers/37763024PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37562003

GET https://conductscience.org/api/papers/v1/37562003/authors?page=2